应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
PHIO Phio Pharmaceuticals
交易中 07-10 15:51:03 EDT
2.43
-0.06
-2.61%
最高
2.51
最低
2.40
成交量
5.46万
今开
2.51
昨收
2.49
日振幅
4.42%
总市值
1,164万
流通市值
1,159万
总股本
479.82万
成交额
13.33万
换手率
1.14%
流通股本
477.91万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Phio Pharmaceuticals Corp.盘中异动 下午盘大幅拉升5.00%
市场透视 · 07-07
Phio Pharmaceuticals Corp.盘中异动 下午盘大幅拉升5.00%
Phio Pharmaceuticals Corp.盘中异动 股价大涨5.07%报2.28美元
市场透视 · 06-30
Phio Pharmaceuticals Corp.盘中异动 股价大涨5.07%报2.28美元
Phio Pharmaceuticals Corp.盘中异动 早盘大幅上涨5.53%
市场透视 · 06-26
Phio Pharmaceuticals Corp.盘中异动 早盘大幅上涨5.53%
HC Wainwright & Co.:重申Phio Pharma(PHIO.US)评级,由买入调整至买入评级, 目标价
智通财经 · 06-25
HC Wainwright & Co.:重申Phio Pharma(PHIO.US)评级,由买入调整至买入评级, 目标价
Phio Pharmaceuticals Corp.盘中异动 股价大跌6.36%报2.21美元
市场透视 · 06-20
Phio Pharmaceuticals Corp.盘中异动 股价大跌6.36%报2.21美元
Phio Pharmaceuticals Corp.盘中异动 临近午盘急速拉升5.29%报2.39美元
市场透视 · 06-16
Phio Pharmaceuticals Corp.盘中异动 临近午盘急速拉升5.29%报2.39美元
Phio Pharmaceuticals Corp.盘中异动 早盘股价大跌5.26%
市场透视 · 06-13
Phio Pharmaceuticals Corp.盘中异动 早盘股价大跌5.26%
Phio Pharmaceuticals Corp.盘中异动 股价大涨5.06%报2.60美元
市场透视 · 06-11
Phio Pharmaceuticals Corp.盘中异动 股价大涨5.06%报2.60美元
Phio Pharmaceuticals Corp.盘中异动 早盘股价大跌5.22%报2.64美元
市场透视 · 06-10
Phio Pharmaceuticals Corp.盘中异动 早盘股价大跌5.22%报2.64美元
Phio Pharmaceuticals Corp.盘中异动 早盘急速拉升5.31%
市场透视 · 06-09
Phio Pharmaceuticals Corp.盘中异动 早盘急速拉升5.31%
Phio Pharmaceuticals Corp.盘中异动 早盘大幅下挫5.01%
市场透视 · 05-09
Phio Pharmaceuticals Corp.盘中异动 早盘大幅下挫5.01%
Phio Pharmaceuticals Corp.盘中异动 早盘股价大跌9.56%
市场透视 · 05-08
Phio Pharmaceuticals Corp.盘中异动 早盘股价大跌9.56%
Phio Pharmaceuticals Corp.5月7日成交额为2256.59万美元
市场透视 · 05-08
Phio Pharmaceuticals Corp.5月7日成交额为2256.59万美元
Phio Pharmaceuticals Corp.5月5日成交额为27.64万美元
市场透视 · 05-06
Phio Pharmaceuticals Corp.5月5日成交额为27.64万美元
Phio Pharmaceuticals Corp.盘中异动 临近收盘股价大跌5.10%
市场透视 · 05-05
Phio Pharmaceuticals Corp.盘中异动 临近收盘股价大跌5.10%
Phio Pharmaceuticals Corp.5月2日成交额为33.30万美元
市场透视 · 05-03
Phio Pharmaceuticals Corp.5月2日成交额为33.30万美元
Phio Pharmaceuticals Corp.4月30日成交额为38.86万美元
市场透视 · 05-01
Phio Pharmaceuticals Corp.4月30日成交额为38.86万美元
Phio Pharmaceuticals Corp.4月29日成交额为48.72万美元
市场透视 · 04-30
Phio Pharmaceuticals Corp.4月29日成交额为48.72万美元
Phio Pharmaceuticals Corp.4月28日成交额为45.27万美元
市场透视 · 04-29
Phio Pharmaceuticals Corp.4月28日成交额为45.27万美元
Phio Pharmaceuticals Corp.盘中异动 早盘股价大跌5.38%
市场透视 · 04-25
Phio Pharmaceuticals Corp.盘中异动 早盘股价大跌5.38%
加载更多
公司概况
公司名称:
Phio Pharmaceuticals
所属市场:
NASDAQ
上市日期:
--
主营业务:
Phio Pharmaceuticals Corp.于2011年9月8日在特拉华州注册成立为Galena的全资子公司,以准备该公司计划从Galena分拆上市,该计划已于2012年4月27日完成。自该日起,该公司作为一家独立的上市公司运营。是一家生物技术公司,专注于发现、开发和商业化基于该公司专有的新一代RNA干扰(“RNAi”)平台的创新疗法。由于能够“沉默”或下调特定基因的表达,使用RNAi的治疗药物具有很大的前景。在2011年9月8日之前,该公司的业务作为Galena Biopharma,Inc.(“Galena”或“母公司”)内的非法人部门运营,该公司是该公司的前母公司。
发行价格:
--
{"stockData":{"symbol":"PHIO","market":"US","secType":"STK","nameCN":"Phio Pharmaceuticals","latestPrice":2.425,"timestamp":1752177053991,"preClose":2.49,"halted":0,"volume":54613,"delay":0,"floatShares":4779136,"shares":4798154,"eps":-9.405447,"marketStatus":"交易中","change":-0.065,"latestTime":"07-10 15:51:03 EDT","open":2.51,"high":2.51,"low":2.4,"amount":133295.7895581,"amplitude":0.044177,"askPrice":2.44,"askSize":300,"bidPrice":2.43,"bidSize":73,"shortable":3,"etf":0,"ttmEps":-9.405447,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1752177600000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":2.49,"preHourTrading":{"tag":"盘前","latestPrice":2.49,"preClose":2.49,"latestTime":"09:26 EDT","volume":2293,"amount":5591.8001442,"timestamp":1752153986306},"postHourTrading":{"tag":"盘后","latestPrice":2.47,"preClose":2.49,"latestTime":"19:14 EDT","volume":718,"amount":1780.47,"timestamp":1752102887379},"volumeRatio":0.363056,"impliedVol":2.2612,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/PHIO","defaultTab":"news","newsList":[{"id":"2549552739","title":"Phio Pharmaceuticals Corp.盘中异动 下午盘大幅拉升5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549552739","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549552739?lang=zh_cn&edition=full","pubTime":"2025-07-08 02:56","pubTimestamp":1751914609,"startTime":"0","endTime":"0","summary":"北京时间2025年07月08日02时56分,Phio Pharmaceuticals Corp.股票出现异动,股价快速拉升5.00%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中,整体跌幅为0.72%。Phio Pharmaceuticals Corp.公司简介:Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司,其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708025650979d599c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708025650979d599c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2548195460","title":"Phio Pharmaceuticals Corp.盘中异动 股价大涨5.07%报2.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548195460","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548195460?lang=zh_cn&edition=full","pubTime":"2025-07-01 00:17","pubTimestamp":1751300230,"startTime":"0","endTime":"0","summary":"北京时间2025年07月01日00时17分,Phio Pharmaceuticals Corp.股票出现波动,股价急速拉升5.07%。截至发稿,该股报2.28美元/股,成交量7.2379万股,换手率1.51%,振幅5.06%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中,整体跌幅为0.62%。Phio Pharmaceuticals Corp.公司简介:Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司,其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701001710a4c705a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701001710a4c705a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2546737391","title":"Phio Pharmaceuticals Corp.盘中异动 早盘大幅上涨5.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546737391","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546737391?lang=zh_cn&edition=full","pubTime":"2025-06-26 23:11","pubTimestamp":1750950690,"startTime":"0","endTime":"0","summary":"北京时间2025年06月26日23时11分,Phio Pharmaceuticals Corp.股票出现波动,股价急速拉升5.53%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中,整体涨幅为0.20%。其相关个股中,Vor Biopharma Inc.、Adial Pharmaceuticals, Inc、Geovax Labs Inc C/Wts 29/09/2025涨幅较大,Adial Pharmaceuticals, Inc、Plus Therapeutics, Inc.、Moleculin Biotech, Inc.较为活跃,换手率分别为1074.66%、261.25%、191.73%,振幅较大的相关个股有Vor Biopharma Inc.、Moleculin Biotech, Inc.、Apollomics Inc C/Wts 01/04/2028 ,振幅分别为91.63%、42.50%、40.05%。Phio Pharmaceuticals Corp.公司简介:Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司,其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506262311309790171f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506262311309790171f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2546241365","title":"HC Wainwright & Co.:重申Phio Pharma(PHIO.US)评级,由买入调整至买入评级, 目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=2546241365","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546241365?lang=zh_cn&edition=full","pubTime":"2025-06-25 22:43","pubTimestamp":1750862589,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2545171787","title":"Phio Pharmaceuticals Corp.盘中异动 股价大跌6.36%报2.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545171787","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545171787?lang=zh_cn&edition=full","pubTime":"2025-06-21 00:35","pubTimestamp":1750437331,"startTime":"0","endTime":"0","summary":"北京时间2025年06月21日00时35分,Phio Pharmaceuticals Corp.股票出现异动,股价快速跳水6.36%。截至发稿,该股报2.21美元/股,成交量7.4547万股,换手率1.55%,振幅4.66%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中,整体跌幅为0.71%。Phio Pharmaceuticals Corp.公司简介:Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司,其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250621003532a714e448&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250621003532a714e448&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2544137601","title":"Phio Pharmaceuticals Corp.盘中异动 临近午盘急速拉升5.29%报2.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544137601","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544137601?lang=zh_cn&edition=full","pubTime":"2025-06-16 23:41","pubTimestamp":1750088478,"startTime":"0","endTime":"0","summary":"北京时间2025年06月16日23时41分,Phio Pharmaceuticals Corp.股票出现异动,股价急速拉升5.29%。截至发稿,该股报2.39美元/股,成交量5.4154万股,换手率1.13%,振幅6.12%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中,整体跌幅为0.46%。Phio Pharmaceuticals Corp.公司简介:Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司,其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025061623411897820b66&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025061623411897820b66&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2543635542","title":"Phio Pharmaceuticals Corp.盘中异动 早盘股价大跌5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2543635542","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543635542?lang=zh_cn&edition=full","pubTime":"2025-06-13 22:13","pubTimestamp":1749824032,"startTime":"0","endTime":"0","summary":"北京时间2025年06月13日22时13分,Phio Pharmaceuticals Corp.股票出现波动,股价急速跳水5.26%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中,整体跌幅为0.46%。Phio Pharmaceuticals Corp.公司简介:Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司,其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613221352a707b265&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613221352a707b265&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2542458008","title":"Phio Pharmaceuticals Corp.盘中异动 股价大涨5.06%报2.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542458008","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542458008?lang=zh_cn&edition=full","pubTime":"2025-06-11 22:02","pubTimestamp":1749650526,"startTime":"0","endTime":"0","summary":"北京时间2025年06月11日22时02分,Phio Pharmaceuticals Corp.股票出现异动,股价大幅拉升5.06%。截至发稿,该股报2.60美元/股,成交量6.7644万股,换手率1.41%,振幅4.45%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中,整体涨幅为0.04%。Phio Pharmaceuticals Corp.公司简介:Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司,其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611220206977b0e78&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611220206977b0e78&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2542488943","title":"Phio Pharmaceuticals Corp.盘中异动 早盘股价大跌5.22%报2.64美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542488943","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542488943?lang=zh_cn&edition=full","pubTime":"2025-06-10 21:31","pubTimestamp":1749562288,"startTime":"0","endTime":"0","summary":"北京时间2025年06月10日21时31分,Phio Pharmaceuticals Corp.股票出现异动,股价急速跳水5.22%。截至发稿,该股报2.64美元/股,成交量2.9846万股,换手率0.62%,振幅1.08%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中,整体涨幅为0.06%。Phio Pharmaceuticals Corp.公司简介:Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司,其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610213128a70238c0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610213128a70238c0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2542338052","title":"Phio Pharmaceuticals Corp.盘中异动 早盘急速拉升5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542338052","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542338052?lang=zh_cn&edition=full","pubTime":"2025-06-09 21:31","pubTimestamp":1749475866,"startTime":"0","endTime":"0","summary":"北京时间2025年06月09日21时31分,Phio Pharmaceuticals Corp.股票出现波动,股价快速拉升5.31%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中,整体涨幅为0.45%。其相关个股中,Klotho Neurosciences, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Synaptogenix, Inc.涨幅较大,Pmgc Holdings Inc.、Klotho Neurosciences, Inc.、Synaptogenix, Inc.较为活跃,换手率分别为974.88%、824.88%、558.45%,振幅较大的相关个股有Elevation Oncology, Inc.、Metsera, Inc.、Jade Biosciences, Inc.,振幅分别为123.48%、117.32%、114.74%。Phio Pharmaceuticals Corp.公司简介:Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司,其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506092131079777e693&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506092131079777e693&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2534301104","title":"Phio Pharmaceuticals Corp.盘中异动 早盘大幅下挫5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534301104","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534301104?lang=zh_cn&edition=full","pubTime":"2025-05-09 22:36","pubTimestamp":1746801377,"startTime":"0","endTime":"0","summary":"北京时间2025年05月09日22时36分,Phio Pharmaceuticals Corp.股票出现异动,股价急速下挫5.01%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中,整体涨幅为0.09%。Phio Pharmaceuticals Corp.公司简介:Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司,其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050922361894f1e2ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050922361894f1e2ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2533130756","title":"Phio Pharmaceuticals Corp.盘中异动 早盘股价大跌9.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533130756","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533130756?lang=zh_cn&edition=full","pubTime":"2025-05-08 21:34","pubTimestamp":1746711292,"startTime":"0","endTime":"0","summary":"北京时间2025年05月08日21时34分,Phio Pharmaceuticals Corp.股票出现波动,股价大幅跳水9.56%。截至发稿,该股报1.85美元/股,成交量25.8095万股,换手率5.40%,振幅6.40%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中,整体跌幅为2.43%。Phio Pharmaceuticals Corp.公司简介:Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司,其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508213452a6d7c485&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508213452a6d7c485&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2533949882","title":"Phio Pharmaceuticals Corp.5月7日成交额为2256.59万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533949882","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533949882?lang=zh_cn&edition=full","pubTime":"2025-05-08 10:25","pubTimestamp":1746671133,"startTime":"0","endTime":"0","summary":"美东时间2025年5月7日,Phio Pharmaceuticals Corp.成交额为2256.59万美元,成交额较昨日增加5194.03%,当日成交量为1145.97万股。Phio Pharmaceuticals Corp.于2025年5月7日涨18.6%,报2.04美元,该股过去5个交易日涨6.25%,年初至今涨13.33%,过去60日涨14.61%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-05-07|2256.59万|5194.03%|1145.97万|#|2025-05-06|42.63万|54.24%|24.43万|#|2025-05-05|27.64万|-17.02%|14.51万|#|2025-05-02|33.30万|17.62%|17.10万|#|2025-05-01|28.32万|-27.14%|14.79万|Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司,其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508102537a6d70863&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508102537a6d70863&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2533516382","title":"Phio Pharmaceuticals Corp.5月5日成交额为27.64万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533516382","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533516382?lang=zh_cn&edition=full","pubTime":"2025-05-06 10:22","pubTimestamp":1746498178,"startTime":"0","endTime":"0","summary":"美东时间2025年5月5日,Phio Pharmaceuticals Corp.成交额为27.64万美元,成交额较昨日减少17.02%,当日成交量为14.51万股。Phio Pharmaceuticals Corp.于2025年5月5日跌4.08%,报1.88美元,该股过去5个交易日跌12.15%,年初至今涨4.44%,过去60日跌7.39%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-05-05|27.64万|-17.02%|14.51万|#|2025-05-02|33.30万|17.62%|17.10万|#|2025-05-01|28.32万|-27.14%|14.79万|#|2025-04-30|38.86万|-20.24%|20.50万|#|2025-04-29|48.72万|7.64%|24.12万|Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司,其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250506102308a6d4697c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250506102308a6d4697c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2533577805","title":"Phio Pharmaceuticals Corp.盘中异动 临近收盘股价大跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533577805","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533577805?lang=zh_cn&edition=full","pubTime":"2025-05-06 03:35","pubTimestamp":1746473708,"startTime":"0","endTime":"0","summary":"北京时间2025年05月06日03时35分,Phio Pharmaceuticals Corp.股票出现异动,股价大幅跳水5.10%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中,整体涨幅为0.31%。Phio Pharmaceuticals Corp.公司简介:Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司,其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250506033508974fd0a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250506033508974fd0a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2532807689","title":"Phio Pharmaceuticals Corp.5月2日成交额为33.30万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532807689","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532807689?lang=zh_cn&edition=full","pubTime":"2025-05-03 10:22","pubTimestamp":1746238940,"startTime":"0","endTime":"0","summary":"美东时间2025年5月2日,Phio Pharmaceuticals Corp.成交额为33.30万美元,成交额较昨日增加17.62%,当日成交量为17.10万股。Phio Pharmaceuticals Corp.于2025年5月2日涨3.7%,报1.96美元,该股过去5个交易日跌3.92%,年初至今涨8.89%,过去60日跌1.51%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-05-02|33.30万|17.62%|17.10万|#|2025-05-01|28.32万|-27.14%|14.79万|#|2025-04-30|38.86万|-20.24%|20.50万|#|2025-04-29|48.72万|7.64%|24.12万|#|2025-04-28|45.27万|-51.84%|21.75万|Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司,其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250503102230a6d1a151&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250503102230a6d1a151&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2532100080","title":"Phio Pharmaceuticals Corp.4月30日成交额为38.86万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532100080","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532100080?lang=zh_cn&edition=full","pubTime":"2025-05-01 10:23","pubTimestamp":1746066183,"startTime":"0","endTime":"0","summary":"美东时间2025年4月30日,Phio Pharmaceuticals Corp.成交额为38.86万美元,成交额较昨日减少20.24%,当日成交量为20.50万股。Phio Pharmaceuticals Corp.于2025年4月30日跌3.03%,报1.92美元,该股过去5个交易日跌5.88%,年初至今涨6.67%,过去60日跌5.88%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-04-30|38.86万|-20.24%|20.50万|#|2025-04-29|48.72万|7.64%|24.12万|#|2025-04-28|45.27万|-51.84%|21.75万|#|2025-04-25|94.00万|-41.61%|44.50万|#|2025-04-24|160.98万|-22.49%|70.61万|Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司,其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501102309a6cf917b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501102309a6cf917b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2531726988","title":"Phio Pharmaceuticals Corp.4月29日成交额为48.72万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531726988","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531726988?lang=zh_cn&edition=full","pubTime":"2025-04-30 10:21","pubTimestamp":1745979703,"startTime":"0","endTime":"0","summary":"美东时间2025年4月29日,Phio Pharmaceuticals Corp.成交额为48.72万美元,成交额较昨日增加7.64%,当日成交量为24.12万股。Phio Pharmaceuticals Corp.于2025年4月29日跌7.48%,报1.98美元,该股过去5个交易日跌21.12%,年初至今涨10.0%,过去60日跌3.88%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-04-29|48.72万|7.64%|24.12万|#|2025-04-28|45.27万|-51.84%|21.75万|#|2025-04-25|94.00万|-41.61%|44.50万|#|2025-04-24|160.98万|-22.49%|70.61万|#|2025-04-23|207.67万|3.45%|97.49万|Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司,其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430102150a6ce28ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430102150a6ce28ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2531214190","title":"Phio Pharmaceuticals Corp.4月28日成交额为45.27万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531214190","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531214190?lang=zh_cn&edition=full","pubTime":"2025-04-29 10:20","pubTimestamp":1745893217,"startTime":"0","endTime":"0","summary":"美东时间2025年4月28日,Phio Pharmaceuticals Corp.成交额为45.27万美元,成交额较昨日减少51.84%,当日成交量为21.75万股。Phio Pharmaceuticals Corp.于2025年4月28日涨4.9%,报2.14美元,该股过去5个交易日跌24.38%,年初至今涨18.89%,过去60日跌3.6%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-04-28|45.27万|-51.84%|21.75万|#|2025-04-25|94.00万|-41.61%|44.50万|#|2025-04-24|160.98万|-22.49%|70.61万|#|2025-04-23|207.67万|3.45%|97.49万|#|2025-04-22|200.74万|12.49%|75.74万|Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司,其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429102025a6cc82ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429102025a6cc82ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2530151608","title":"Phio Pharmaceuticals Corp.盘中异动 早盘股价大跌5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530151608","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530151608?lang=zh_cn&edition=full","pubTime":"2025-04-25 22:46","pubTimestamp":1745592410,"startTime":"0","endTime":"0","summary":"北京时间2025年04月25日22时46分,Phio Pharmaceuticals Corp.股票出现波动,股价大幅跳水5.38%。截至发稿,该股报2.11美元/股,成交量15.4172万股,换手率3.23%,振幅6.73%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中,整体跌幅为0.34%。Phio Pharmaceuticals Corp.公司简介:Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司,其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042522465194e2992a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042522465194e2992a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHIO","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.phiopharma.com","stockEarnings":[{"period":"1week","weight":0.004},{"period":"1month","weight":-0.1075},{"period":"3month","weight":0.5091},{"period":"6month","weight":0.4734},{"period":"1year","weight":-0.5522},{"period":"ytd","weight":0.3833}],"compareEarnings":[{"period":"1week","weight":0.0058},{"period":"1month","weight":0.0407},{"period":"3month","weight":0.1896},{"period":"6month","weight":0.0751},{"period":"1year","weight":0.1228},{"period":"ytd","weight":0.0648}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Phio Pharmaceuticals Corp.于2011年9月8日在特拉华州注册成立为Galena的全资子公司,以准备该公司计划从Galena分拆上市,该计划已于2012年4月27日完成。自该日起,该公司作为一家独立的上市公司运营。是一家生物技术公司,专注于发现、开发和商业化基于该公司专有的新一代RNA干扰(“RNAi”)平台的创新疗法。由于能够“沉默”或下调特定基因的表达,使用RNAi的治疗药物具有很大的前景。在2011年9月8日之前,该公司的业务作为Galena Biopharma,Inc.(“Galena”或“母公司”)内的非法人部门运营,该公司是该公司的前母公司。","yearOnYearQuotes":[{"month":1,"riseRate":0.363636,"avgChangeRate":-0.043516},{"month":2,"riseRate":0.363636,"avgChangeRate":-0.058261},{"month":3,"riseRate":0.416667,"avgChangeRate":-0.080913},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.07123},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.031751},{"month":6,"riseRate":0.5,"avgChangeRate":-0.004305},{"month":7,"riseRate":0.416667,"avgChangeRate":-0.089541},{"month":8,"riseRate":0.272727,"avgChangeRate":-0.030187},{"month":9,"riseRate":0.090909,"avgChangeRate":-0.131629},{"month":10,"riseRate":0.272727,"avgChangeRate":-0.131123},{"month":11,"riseRate":0.363636,"avgChangeRate":-0.063336},{"month":12,"riseRate":0.181818,"avgChangeRate":-0.144776}],"exchange":"NASDAQ","name":"Phio Pharmaceuticals","nameEN":"Phio Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Phio Pharmaceuticals(PHIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Phio Pharmaceuticals(PHIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Phio Pharmaceuticals,PHIO,Phio Pharmaceuticals股票,Phio Pharmaceuticals股票老虎,Phio Pharmaceuticals股票老虎国际,Phio Pharmaceuticals行情,Phio Pharmaceuticals股票行情,Phio Pharmaceuticals股价,Phio Pharmaceuticals股市,Phio Pharmaceuticals股票价格,Phio Pharmaceuticals股票交易,Phio Pharmaceuticals股票购买,Phio Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Phio Pharmaceuticals(PHIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Phio Pharmaceuticals(PHIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}